We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URBN icon
201
Urban Outfitters
URBN
$6.38B
$4.95M 0.12%
143,250
-18,020
-11% -$590K
PBH icon
202
Prestige Consumer Healthcare
PBH
$2.35B
$4.93M 0.12%
102,187
-34,001
-25% -$1.72M
DAL icon
203
Delta Air Lines
DAL
$57.8B
$4.89M 0.12%
124,165
-40,300
-25% -$1.52M
TVTX icon
204
Travere Therapeutics
TVTX
$5.24B
$4.89M 0.12%
218,325
+191,380
+710% +$3.64M
GBX icon
205
The Greenbrier Companies
GBX
$1.53B
$4.83M 0.12%
+136,925
New +$4.48M
PVH icon
206
PVH
PVH
$4.02B
$4.81M 0.12%
+43,525
New +$4.5M
TXRH icon
207
Texas Roadhouse
TXRH
$13.6B
$4.73M 0.12%
121,165
-98,265
-45% -$4.39M
CENTA icon
208
Central Garden & Pet Co Class A
CENTA
$2.36B
$4.7M 0.12%
236,838
-73,750
-24% -$1.4M
RDC
209
DELISTED
Rowan Companies Plc
RDC
$4.67M 0.12%
307,927
-221,188
-42% -$3.24M
RUTH
210
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$4.63M 0.11%
328,260
-35,250
-10% -$539K
VEA icon
211
Vanguard FTSE Developed Markets ETF
VEA
$229B
$4.58M 0.11%
122,429
-4,318
-3% -$159K
MCK icon
212
McKesson
MCK
$100B
$4.57M 0.11%
27,419
+3,467
+14% +$646K
VSH icon
213
Vishay Intertechnology
VSH
$5.28B
$4.55M 0.11%
322,830
-29,155
-8% -$392K
CTAS icon
214
Cintas
CTAS
$81.8B
$4.51M 0.11%
160,112
-50,720
-24% -$1.39M
BLMN icon
215
Bloomin' Brands
BLMN
$740M
$4.45M 0.11%
257,830
-70,960
-22% -$1.32M
NSC icon
216
Norfolk Southern
NSC
$75.2B
$4.38M 0.11%
45,136
-555
-1% -$50.5K
IBM icon
217
IBM
IBM
$206B
$4.36M 0.11%
28,686
+3,364
+13% +$510K
CAL icon
218
Caleres
CAL
$430M
$4.24M 0.1%
167,448
-21,310
-11% -$542K
EXR icon
219
Extra Space Storage
EXR
$31.1B
$4.22M 0.1%
53,175
-2,062
-4% -$174K
MMSI icon
220
Merit Medical Systems
MMSI
$5.05B
$4.22M 0.1%
173,699
-141,105
-45% -$3.26M
TEP
221
DELISTED
Tallgrass Energy Partners, LP
TEP
$4.21M 0.1%
87,410
-9,700
-10% -$452K
LABL
222
DELISTED
Multi-Color Corp
LABL
$4.21M 0.1%
63,739
-8,285
-12% -$546K
TCBK icon
223
TriCo Bancshares
TCBK
$1.84B
$4.17M 0.1%
155,848
-19,570
-11% -$526K
GFF icon
224
Griffon
GFF
$3.98B
$4.13M 0.1%
243,079
-24,980
-9% -$426K
BC icon
225
Brunswick
BC
$5.07B
$4.11M 0.1%
84,186
-7,279
-8% -$348K

Similar funds

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.